Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 25, 2000
The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs
H Schütte, M Witzenrath, K Mayer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 6, 2001
Alveolar epithelial barrier functions in ventilated perfused rabbit lungs
H A Ghofrani, M G Kohstall, N Weissmann, et al.
Journal of the American College of Cardiology
|
October 5, 2001
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation
R Wiedemann, H A Ghofrani, N Weissmann, et al.
The American Journal of Physiology
|
January 14, 1999
Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction
N Weissmann, R Voswinckel, T Hardebusch, et al.
The European Respiratory Journal
|
April 10, 2010
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge
L Kiss, H Schütte, W Padberg, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 21, 2006
[Pulmonary tissue regeneration -- a hope for the future]
R Voswinckel, K Ahlbrecht, J C Wolff, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 2, 2000
Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs
N Weissmann, R Voswinckel, A Tadic, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 25, 2000
The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs
H Schütte, M Witzenrath, K Mayer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 6, 2001
Alveolar epithelial barrier functions in ventilated perfused rabbit lungs
H A Ghofrani, M G Kohstall, N Weissmann, et al.
Journal of the American College of Cardiology
|
October 5, 2001
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation
R Wiedemann, H A Ghofrani, N Weissmann, et al.
The American Journal of Physiology
|
January 14, 1999
Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction
N Weissmann, R Voswinckel, T Hardebusch, et al.
The European Respiratory Journal
|
April 10, 2010
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge
L Kiss, H Schütte, W Padberg, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 21, 2006
[Pulmonary tissue regeneration -- a hope for the future]
R Voswinckel, K Ahlbrecht, J C Wolff, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 2, 2000
Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs
N Weissmann, R Voswinckel, A Tadic, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
Page
of 7